MENU

Clinical Testing and Implication of MSI Testing in GI Cancers

Speaker
  • Gerard Blobe, MD, PhD

    Professor of Medicine, Pharmacology and Cancer Biology at Duke University School of Medicine, Associate Director of Training and Education for the Duke Cancer Institute
    BIOGRAPHY

Abstract

Dr. Blobe will be discussing the use of a universal MSI testing approach to identify candidates for immunotherapeutic treatment of Colorectal and other GI Cancers, including Biliary Tract, Esophageal, Anal, and Gastric Cancers.